Global Markets
The US FDA discloses a June 22nd warning letter to Sanofi's (SAN FP) Genzyme after a facility inspection
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
